Clinical trials recruiting for Prostate Cancer Metastatic
27
Recruiting trials
30
US states with sites
43
Countries
0%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Maryland | 3 |
| Texas | 3 |
| California | 2 |
| Illinois | 2 |
| New York | 2 |
| Pennsylvania | 2 |
| Wisconsin | 2 |
| Colorado | 1 |
| Connecticut | 1 |
| District of Columbia | 1 |
| Florida | 1 |
| Iowa | 1 |
Top cities
Baltimore, Maryland 3Houston, Texas 3Chicago, Illinois 2Aberdeen, South Dakota 1Aurora, Colorado 1Austin, Texas 1Boston, Massachusetts 1Charleston, South Carolina 1Charlottesville, Virginia 1Cleveland, Ohio 1
Self-screener
Recruiting trials
- 7-Days Water-Only Fasting or Ketone Supplementation Trial in Prostate Cancer
- A FIH, Phase I/IIa, Trial Assessing Feasibility of Administrations of TIL-based Immunotherapy in Patients With Metastatic CRC and PC
- A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Expressing Fibroblast Growth Factor Receptor 1
- A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate Cancer
- ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)
- ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials
- Castrate Resistant Prostate Cancer Enhertu Therapy
- Clinical Application of the J-PET Scanner Prototype
- Data Collection in Lutetium Treated Prostate Cancer: Recording of Progression and Tumor Characteristics
- Dutch National Randomized Study: PSMA-PET/CT As a Triage Tool for Pelvic Lymph Node Dissection in Prostatectomy Patients
- Dynamic 68Ga-PSMA and 18F-FDG PET/CT Analysis Prior to 177Lu-PSMA
- Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate Cancer
- Exercise in Prostate Cancer
- Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy
- FTT PET/CT in Metastatic Prostate Cancer
- Geriatric Assessment and Technology Evaluation in Prostate Cancer
- Metastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate Cancer
- Metastasis-directed Therapy for Oligorecurrent Prostate Cancer
- National Danish Protocol. Surgery+ SBRT for M1 Prostate Cancer Patients
- PSMA PET for Treatment Response evaLuation of systemIC Therapies in prostAte caNcer (PELICAN)
- Pembrolizumab, Carboplatin and Cabazitaxel in Aggressive Metastatic Castration Resistant Prostate Cancer (PEAPOD_FOS)
- Radiotherapy to Consolidate Systemic Response in Metastatic Prostate Cancer (ANCHOR-Prostate)
- Standard of Care +/- 177Lu-PSMA-617 In de Novo mHSPC Patients With Poor PSA Response (PEACE6-Poor Responders)
- Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
- Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Prostate Cancers in Algeria
- Treatment of Patients With Progressive mCRPC With 177Lu-PSMA-617
- Tumor Genomic Pre-test Counseling Tool for Black or African-American Men With Prostate Cancer
Related conditions
Trials recruiting for Prostate Cancer Metastatic often also study these conditions. Each links to its own recruiting-trial list.
Prostate cancer 1234Radiation Therapy 6Prostatic Neoplasms 36Prostatic Hyperplasia 4Prostate Cancer Recurrent 11Prostate Cancer (Post Prostatectomy) 14Prostate Cancer Patients Treated by Radiotherapy 7Prostate Cancer (Diagnosis) 26Prostate Cancer (CRPC) 3Prostate Cancer (Adenocarcinoma) 43
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Prostate Cancer Metastatic trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.